insights_auto
Pse është ulur ALNY 2,43%?
Zhytu më thellëchevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
227,02Â US$
arrow_downward
-2,43%(-5,66) 1D
226,00Â US$
arrow_downward
-0,45% (-1,02)bedtimeJashtë orarit
Mbyllur: 12 tet, 4:00:01 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALNY...
Hap
233,13Â US$
I lartë
233,60Â US$
I ulët
226,35Â US$
Kapitalizimi i tregut
30,38Â mld
Vëllimi mesatar
1,49Â mln
Vëllimi
0,00
Raporti çmim/fitim
38,64
Maksimumi 52-javor
495,55Â US$
Minimumi 52-javor
197,81Â US$
Fitimet për aksion
5,88Â US$
Beta
0,28
Aksionet në qarkullim
133,81Â mln
Numri i punonjësve
2 mijë
Hap
233,13Â US$
I lartë
233,60Â US$
I ulët
226,35Â US$
Kapitalizimi i tregut
30,38Â mld
Vëllimi mesatar
1,49Â mln
Vëllimi
0,00
Raporti çmim/fitim
38,64
Maksimumi 52-javor
495,55Â US$
Minimumi 52-javor
197,81Â US$
Fitimet për aksion
5,88Â US$
Beta
0,28
Aksionet në qarkullim
133,81Â mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
The Globe and Mail
·
8 orë më parë
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV)
Stocks Down Under
·
13 orë më parë
Alnylam Pharmaceuticals (NDQ:ALNY): This RNAi Pioneer Is Becoming A Cardiometabolic Heavyweight Right Before Our Eyes
Investing.com
·
1 ditë më parë
Alnylam EVP Bryan Supran sells $398,855 in shares
Investing.com Nigeria
·
1 ditë më parë
Form 4 Alnylam Pharmaceuticals Inc For: 11 October By Investing.com
Profili
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Rreth Alnylam Pharmaceuticals, Inc.